Transmuscular Quadratus Lumborum Block on Post-Operative Analgesia After Total Hip Arthroplasty
Quadratus Lumborum Block

About this trial
This is an interventional treatment trial for Quadratus Lumborum Block
Eligibility Criteria
Inclusion Criteria:
- 75 patients, aged between 21- 80 years old, of both sex American society of Anesthesiology I - III scheduled for total hip replacement surgery.
Exclusion Criteria:
- Patient refusal.
- Coagulopathy
- Spinal deformities
- Peripheral neuropathy; sensory disorders in the leg requiring surgery and chronic pain.
- Mental dysfunction, psychiatric illnesses and cognitive dysfunction.
- History of drug abuse &chronic analgesic use
Sites / Locations
- Tanata university hospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Sham Comparator
Active Comparator
Active Comparator
Group I: Control Group
Group II:( transverse trans muscular Quadratus lumborum group).
Group III : paraspinous sagittal approach of Quadratus lumborum BLOCK
Patients in this group will receive ipsilateral sham ultrasound-guided block via subcutaneous injection of 1 ml of normal saline after surgery.
patients in this group will receive an ipsilateral single-shot of paraspinous sagittal approach of Quadratus lumborum BLOCK(30 ml of plain bupivacaine 0.25%) after surgery using ultrasonographic guidance.
patients in this group will receive an ipsilateral single-shot of paraspinous sagittal approach of Quadratus lumborum BLOCK (30 ml of plain bupivacaine 0.25%) after surgery using ultrasonographic guidance.